JENNIFER WINTER: Open Payments
NPI 1740280056 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,660 in 107 payments from 19 companies in 2025. Trend: 2023 $672 · 2024 $1,241 · 2025 $2,660
Food & beverage: $2,172Travel & lodging: $488
| Company | Payments | Amount |
|---|---|---|
| Arthrex, Inc. | 7 | $632 |
| Janssen Biotech, Inc. | 26 | $539 |
| ABBVIE INC. | 24 | $237 |
| UCB, Inc. | 11 | $224 |
| Organon LLC | 7 | $173 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $142 |
| Galderma Laboratories, L.P. | 6 | $121 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ILUMYA, NEMLUVIO, SILIQ, COSENTYX, HADLIMA.
Industry payments across WA — which companies pay providers there.
